Sandman Paul W 4
4 · PDL BIOPHARMA, INC. · Filed Jun 10, 2010
Insider Transaction Report
Form 4
SANDMAN PAUL W
Director
Transactions
- Award
Common Stock
2010-06-09$5.05/sh+9,900$49,995→ 26,883 total
Footnotes (1)
- [F1]The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL Biopharma, Inc. During the one-year vesting period, the grant recipient will have the right to vote the shares and receive any dividends paid, except that dividends and other distributions will be accumulated and paid on the earlier of the same vesting conditions as the original award or March 15th of the year following the payment of such dividend or distribution to all stockholders.